|
1
|
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
|
J Natl Cancer Inst
|
1998
|
5.30
|
|
2
|
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.
|
Clin Cancer Res
|
2001
|
2.28
|
|
3
|
Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
|
J Neurosurg
|
2000
|
1.82
|
|
4
|
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.
|
Int J Radiat Oncol Biol Phys
|
2000
|
1.32
|
|
5
|
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
|
Am J Pathol
|
2001
|
1.04
|
|
6
|
Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea.
|
Cancer Res
|
2001
|
0.91
|
|
7
|
The hPMS2 exon 5 mutation and malignant glioma. Case report.
|
J Neurosurg
|
1999
|
0.75
|